Vaxart, Inc. Research and Development Expense
Vaxart, Inc. (VXRT) reported Research and Development Expense of $33.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Vaxart, Inc. research and development expense for the quarter ending 2026-06-30 was $33.75M, a 32.13% decline year-over-year.
- Vaxart, Inc. research and development expense for the quarter ending 2026-03-31 was $29.41M, a 4.33% decline year-over-year.
- Vaxart, Inc. research and development expense for the quarter ending 2025-12-31 was $45.15M, a 99.30% increase year-over-year.
- Vaxart, Inc. research and development expense for the quarter ending 2025-09-30 was $75.95M, a 404.10% increase year-over-year.
- Vaxart, Inc. research and development expense for fiscal 2023 was $68.14M, a 15.93% decline from fiscal 2022.
- Vaxart, Inc. research and development expense for fiscal 2022 was $81.05M, a 66.27% increase from fiscal 2021.
- Vaxart, Inc. research and development expense for fiscal 2021 was $48.75M, a 145.43% increase from fiscal 2020.
- Vaxart, Inc. research and development expense for fiscal 2020 was $19.86M, a 36.61% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $33.75M 10-Q · filed 2026-08-06 | $63.17M 10-Q · filed 2026-08-06 | $108.32M derived: sum of 3 quarters · filed 2026-08-06 | $184.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $29.41M S-1 · filed 2026-05-08 | $74.56M derived: sum of 2 quarters · filed 2026-05-08 | $150.51M derived: sum of 3 quarters · filed 2026-05-08 | $200.25M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $45.15M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $121.10M derived: sum of 2 quarters · filed 2026-05-08 | $170.83M derived: sum of 3 quarters · filed 2026-08-06 | $201.58M S-1 · filed 2026-05-08 | ||||
| 2025-09-30 | $75.95M 10-Q · filed 2025-11-13 | $125.68M derived: sum of 2 quarters · filed 2026-08-06 | $156.43M 10-Q · filed 2025-11-13 | $179.08M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $49.73M 10-Q · filed 2026-08-06 | $80.48M 10-Q · filed 2026-08-06 | $103.13M derived: sum of 3 quarters · filed 2026-08-06 | $118.20M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $30.74M S-1 · filed 2026-05-08 | $53.40M derived: sum of 2 quarters · filed 2026-05-08 | $68.46M derived: sum of 3 quarters · filed 2026-05-08 | $85.94M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $22.65M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $37.72M derived: sum of 2 quarters · filed 2026-05-08 | $55.20M derived: sum of 3 quarters · filed 2026-05-08 | $74.21M S-1 · filed 2026-05-08 | ||||
| 2024-09-30 | $15.07M 10-Q · filed 2025-11-13 | $32.55M derived: sum of 2 quarters · filed 2025-11-13 | $51.56M 10-Q · filed 2025-11-13 | $66.26M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $17.48M 10-Q · filed 2025-08-13 | $36.49M 10-Q · filed 2025-08-13 | $51.20M derived: sum of 3 quarters · filed 2025-08-13 | $66.20M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $19.01M 10-Q · filed 2025-05-13 | $33.72M derived: sum of 2 quarters · filed 2025-05-13 | $48.72M derived: sum of 3 quarters · filed 2025-05-13 | $67.53M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $14.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $29.71M derived: sum of 2 quarters · filed 2025-03-20 | $48.52M derived: sum of 3 quarters · filed 2025-03-20 | $68.14M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $15.00M 10-Q · filed 2024-11-13 | $33.81M derived: sum of 2 quarters · filed 2024-11-13 | $53.44M 10-Q · filed 2024-11-13 | $73.90M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $18.81M 10-Q · filed 2024-08-08 | $38.44M 10-Q · filed 2024-08-08 | $58.89M derived: sum of 3 quarters · filed 2024-08-08 | $81.36M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $19.62M 10-Q · filed 2024-05-13 | $40.08M derived: sum of 2 quarters · filed 2024-05-13 | $62.55M derived: sum of 3 quarters · filed 2024-05-13 | $82.47M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $20.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $42.92M derived: sum of 2 quarters · filed 2024-03-14 | $62.85M derived: sum of 3 quarters · filed 2024-03-14 | $81.05M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $22.47M 10-Q · filed 2023-11-02 | $42.39M derived: sum of 2 quarters · filed 2023-11-02 | $60.59M 10-Q · filed 2023-11-02 | $76.13M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $19.93M 10-Q · filed 2023-08-03 | $38.13M 10-Q · filed 2023-08-03 | $53.66M derived: sum of 3 quarters · filed 2023-08-03 | $66.07M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $18.20M 10-Q · filed 2023-05-04 | $33.73M derived: sum of 2 quarters · filed 2023-05-04 | $46.14M derived: sum of 3 quarters · filed 2023-05-04 | $56.88M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $15.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $27.94M derived: sum of 2 quarters · filed 2023-03-15 | $38.68M derived: sum of 3 quarters · filed 2023-03-15 | $48.75M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $12.41M 10-Q · filed 2022-11-09 | $23.15M derived: sum of 2 quarters · filed 2022-11-09 | $33.22M 10-Q · filed 2022-11-09 | $41.81M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $10.74M 10-Q · filed 2022-08-08 | $20.81M 10-Q · filed 2022-08-08 | $29.40M derived: sum of 3 quarters · filed 2022-08-08 | $34.02M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $10.07M 10-Q · filed 2022-05-09 | $18.66M derived: sum of 2 quarters · filed 2022-05-09 | $23.28M derived: sum of 3 quarters · filed 2022-05-09 | $28.39M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $8.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $13.21M derived: sum of 2 quarters · filed 2022-02-24 | $18.32M derived: sum of 3 quarters · filed 2022-02-24 | $19.86M 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | $4.62M 10-Q · filed 2021-11-04 | $9.73M derived: sum of 2 quarters · filed 2021-11-04 | $11.27M 10-Q · filed 2021-11-04 | $14.56M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $5.11M 10-Q · filed 2021-08-05 | $6.66M 10-Q · filed 2021-08-05 | $9.95M derived: sum of 3 quarters · filed 2022-02-24 | $13.66M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $1.54M 10-Q · filed 2021-05-06 | $4.83M derived: sum of 2 quarters · filed 2022-02-24 | $8.55M derived: sum of 3 quarters · filed 2022-02-24 | $12.25M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $7.00M derived: sum of 2 quarters · filed 2022-02-24 | $10.71M derived: sum of 3 quarters · filed 2022-02-24 | $14.54M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $3.71M 10-Q · filed 2020-11-12 | $7.42M derived: sum of 2 quarters · filed 2020-11-12 | $11.25M 10-Q · filed 2020-11-12 | $15.72M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $3.71M 10-Q · filed 2020-08-06 | $7.54M 10-Q · filed 2020-08-06 | $12.01M derived: sum of 3 quarters · filed 2021-02-25 | $16.39M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $3.83M 10-Q · filed 2020-05-12 | $8.30M derived: sum of 2 quarters · filed 2021-02-25 | $12.68M derived: sum of 3 quarters · filed 2021-02-25 | $17.70M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $8.86M derived: sum of 2 quarters · filed 2021-02-25 | $13.87M derived: sum of 3 quarters · filed 2021-02-25 | $17.27M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $4.38M 10-Q · filed 2019-11-12 | $9.39M derived: sum of 2 quarters · filed 2019-11-12 | $12.80M 10-Q · filed 2019-11-12 | $15.30M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $5.01M 10-Q · filed 2019-08-08 | $8.42M 10-Q · filed 2019-08-08 | $10.92M derived: sum of 3 quarters · filed 2019-08-08 | $13.17M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $3.41M 10-Q · filed 2019-05-09 | $5.91M derived: sum of 2 quarters · filed 2019-05-09 | $8.15M derived: sum of 3 quarters · filed 2019-05-09 | $12.48M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $2.50M 10-Q · filed 2018-02-06 | $5.30M 10-Q · filed 2018-02-06 | $9.07M derived: sum of 3 quarters · filed 2018-11-13 | $12.36M 10-K · filed 2019-02-06 | ||||
| 2017-09-30 | $2.25M 10-Q · filed 2018-11-13 | $2.80M 10-Q · filed 2017-11-07 | $6.57M derived: sum of 2 quarters · filed 2018-11-13 | $10.45M 10-Q · filed 2018-11-13 | $20.65M derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | $4.32M 10-Q · filed 2018-08-10 | $8.20M 10-Q · filed 2018-08-10 | $18.40M derived: sum of 3 quarters · filed 2018-08-10 | $28.30M 10-K · filed 2017-09-01 | ||||
| 2017-03-31 | $3.88M 10-Q · filed 2018-05-15 | $6.80M 10-Q · filed 2017-05-08 | $14.08M derived: sum of 2 quarters · filed 2018-05-15 | $24.60M 10-Q · filed 2017-05-08 | $27.58M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $10.20M 10-Q · filed 2018-02-06 | $17.80M 10-Q · filed 2018-02-06 | $23.70M derived: sum of 3 quarters · filed 2018-02-06 | $32.20M derived: sum of 4 quarters · filed 2018-02-06 | ||||
| 2016-09-30 | $7.60M 10-Q · filed 2017-11-07 | $13.50M derived: sum of 2 quarters · filed 2017-11-07 | $22.00M derived: sum of 3 quarters · filed 2017-11-07 | $28.30M derived: sum of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | $14.40M derived: sum of 2 quarters · filed 2017-09-01 | $20.70M derived: sum of 3 quarters · filed 2017-09-01 | $26.30M 10-K · filed 2017-09-01 | ||||
| 2016-03-31 | $8.50M 10-Q · filed 2017-05-08 | $14.80M derived: sum of 2 quarters · filed 2017-05-08 | $20.40M 10-Q · filed 2017-05-08 | $25.60M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2015-12-31 | $6.30M 10-Q · filed 2017-02-06 | $11.80M 10-Q · filed 2017-02-06 | $17.10M derived: sum of 3 quarters · filed 2017-02-06 | $21.90M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-09-30 | $5.50M 10-Q · filed 2016-11-08 | $10.80M derived: sum of 2 quarters · filed 2016-11-08 | $15.60M derived: sum of 3 quarters · filed 2016-11-08 | $20.40M derived: sum of 4 quarters · filed 2016-11-08 | ||||
| 2015-06-30 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $10.10M derived: sum of 2 quarters · filed 2016-09-13 | $14.90M derived: sum of 3 quarters · filed 2016-09-13 | $19.80M 10-K · filed 2016-09-13 | ||||
| 2015-03-31 | $4.80M 10-Q · filed 2016-05-10 | $9.60M derived: sum of 2 quarters · filed 2016-05-10 | $14.50M 10-Q · filed 2016-05-10 | $20.70M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-12-31 | $4.80M 10-Q · filed 2016-02-08 | $9.70M 10-Q · filed 2016-02-08 | $15.90M derived: sum of 3 quarters · filed 2016-09-13 | $20.00M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-09-30 | $4.90M 10-Q · filed 2015-11-06 | $11.10M derived: sum of 2 quarters · filed 2016-09-13 | $15.20M derived: sum of 3 quarters · filed 2016-09-13 | $19.40M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-06-30 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $10.30M derived: sum of 2 quarters · filed 2016-09-13 | $14.50M derived: sum of 3 quarters · filed 2016-09-13 | $17.50M 10-K · filed 2016-09-13 | ||||
| 2014-03-31 | $4.10M 10-Q · filed 2015-05-08 | $8.30M derived: sum of 2 quarters · filed 2015-05-08 | $11.30M 10-Q · filed 2015-05-08 | $17.60M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-12-31 | $4.20M 10-Q · filed 2015-02-06 | $7.10M 10-Q · filed 2015-02-06 | $13.50M derived: sum of 3 quarters · filed 2015-09-11 | $18.00M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-09-30 | $3.00M 10-Q · filed 2014-11-07 | $9.30M derived: sum of 2 quarters · filed 2015-09-11 | $13.80M derived: sum of 3 quarters · filed 2015-09-11 | $18.40M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-06-30 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | $10.80M derived: sum of 2 quarters · filed 2015-09-11 | $15.40M derived: sum of 3 quarters · filed 2015-09-11 | $19.90M 10-K · filed 2015-09-11 | $19.20M 10-K · filed 2013-09-27 | |||
| 2013-03-31 | $4.50M 10-Q · filed 2014-05-12 | $4.94M 10-Q · filed 2013-05-10 | $9.10M derived: sum of 2 quarters · filed 2014-05-12 | $13.60M 10-Q · filed 2014-05-12 | $13.58M 10-Q · filed 2013-05-10 | $15.03M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $4.60M 10-Q · filed 2014-02-10 | $4.05M 10-Q · filed 2013-02-11 | $9.10M 10-Q · filed 2014-02-10 | $8.65M 10-Q · filed 2013-02-11 | $10.53M derived: sum of 3 quarters · filed 2014-02-10 | $16.24M derived: sum of 4 quarters · filed 2014-02-10 | ||
| 2012-09-30 | $4.60M 10-Q · filed 2013-11-12 | $3.15M 10-Q · filed 2012-11-08 | $5.93M derived: sum of 2 quarters · filed 2013-11-12 | $5.99M 10-Q · filed 2012-11-08 | $17.37M derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2012-06-30 | $1.33M 10-Q · filed 2012-08-09 | $2.85M 10-Q · filed 2012-08-09 | $12.77M derived: sum of 3 quarters · filed 2013-05-10 | $24.10M 10-K · filed 2014-09-30 | ||||
| 2012-03-31 | $5.71M 10-Q · filed 2013-05-10 | $1.52M 10-Q · filed 2012-05-10 | $11.44M derived: sum of 2 quarters · filed 2013-05-10 | $17.77M 10-Q · filed 2013-05-10 | $22.28M derived: sum of 4 quarters · filed 2013-05-10 | |||
| 2011-12-31 | $5.73M 10-Q · filed 2013-02-11 | $12.06M 10-Q · filed 2013-02-11 | $16.57M derived: sum of 3 quarters · filed 2013-02-11 | $17.77M 10-K · filed 2012-03-14 | ||||
| 2011-09-24 | $4.39M 10-Q · filed 2012-11-08 | $10.84M derived: sum of 2 quarters · filed 2012-08-09 | $16.18M 10-Q · filed 2012-11-08 | $23.02M derived: sum of 4 quarters · filed 2012-08-09 | ||||
| 2011-06-30 | $33.50M 10-K · filed 2013-09-27 | |||||||
| 2011-06-25 | $6.46M 10-Q · filed 2012-08-09 | $11.79M 10-Q · filed 2012-08-09 | $18.63M derived: sum of 3 quarters · filed 2012-08-09 | $25.43M derived: sum of 4 quarters · filed 2012-08-09 | ||||
| 2011-03-26 | $5.33M 10-Q · filed 2012-05-10 | $12.18M derived: sum of 2 quarters · filed 2012-05-10 | $18.98M derived: sum of 3 quarters · filed 2012-05-10 | $25.50M derived: sum of 4 quarters · filed 2012-05-10 | ||||
| 2010-12-25 | $6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $13.64M derived: sum of 2 quarters · filed 2012-03-14 | $20.17M derived: sum of 3 quarters · filed 2012-03-14 | $26.08M 10-K · filed 2012-03-14 | ||||
| 2010-09-25 | $6.80M 10-Q · filed 2011-11-02 | $13.33M derived: sum of 2 quarters · filed 2011-11-02 | $19.24M 10-Q · filed 2011-11-02 | |||||
| 2010-06-26 | $6.53M 10-Q · filed 2011-08-03 | $12.44M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-26 | $16.49M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |